Press & Media

Healthcare Professional Webinar - "COVID-19 learnings overview - health and wellbeing in the workplace"

Healthcare Professional Webinar - "Psychology support in diabetes care - discussing the evidence"

Did you know that we have collaborated with patient organisation JDRF (the Juvenile Diabetes Research Foundation) for over ten years? This article shares the ways in which we work together and some of the things we’ve collectively achieved.

Roche Diabetes Care announced today that it has been selected as a finalist in the ‘Most Promising Agile Transformation’ category in the Pharma Awards Europe 2020.

Roche Diabetes Care has been awarded a Silver standard in the Patient Partnership Index in recognition of its support of type 1 diabetes charity JDRF (the Juvenile Diabetes Research Foundation).

Roche Diabetes Care today announced that it is delighted to have the support of pharmacy-led, health and beauty retailer, Boots, in offering its customers free access to the mySugr Pro diabetes management.

Innovation in diabetes care in Wales. Learning from lockdown and future implementation ideas.

The ongoing COVID-19 pandemic is an unprecedented challenge for the health system, necessitating new ways of working. As a company, we wish to offer our support by providing a year’s free access for all adults with diabetes to our diabetes management app, mySugr Pro, to help both patients and clinicians.

The ongoing COVID-19 pandemic is an unprecedented challenge for the health system, necessitating new ways of working. As a company, we wish to offer our support by providing a year’s free access for all adults with diabetes to our diabetes management app, mySugr Pro, to help both patients and clinicians.

The ongoing COVID-19 pandemic is an unprecedented challenge for the health system, necessitating new ways of working. As a company, we wish to offer our support by providing a year’s free access for all adults with diabetes to our diabetes management app, mySugr Pro, to help both patients and clinicians.

Roche today announced that it has obtained the CE Mark for its Accu-Chek SugarView app. This paves the way for the launch of the innovative diabetes management solution in the UK, across Europe and further countries around the world requiring the CE Mark.

Diabetes needs to be addressed with an integrated, collaborative and personalised approach in order to cover all the different angles of this complex condition and meet the individual goals of each person with diabetes or at risk of developing the disease.

Roche today announced its renewed support of the Phelophepa primary healthcare trains in South Africa as the main external sponsor to mark this milestone 25th anniversary.

Since the launch of the Accu-Chek Solo micropump, 200 people with type 1 diabetes in the UK are now using the device as part of a ‘Managed Access Programme’ benefiting from the latest in insulin delivery system technology.

Roche Diabetes Care has partnered with OurPath since October 2017 to promote OurPath's healthy lifestyle programme throughout the UK and Ireland.

Today, Roche Diabetes Care announced that the price of Accu-Chek Performa Nano blood glucose test strips will be reduced from £9.95 to £7.50 on the NHS Drug Tarriff.

Roche today announced promising results from a new study which supports the use of real-world data, including electronic medical record data, to predict the risk of chronic kidney disease (CKD) in individuals with diabetes.

Roche and mySugr announced today that the two partners have signed an agreement under which Roche acquired all shares of mySugr GBMH,